Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase II Clinical Trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Hanma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc
Step 3: Medication and Prior Authorization Support If prescribed, Klinic will handle the prior authorization process
Once reconstituted, the solution must stay liquid
Tirzepatide dosing Starts at 2.5 mg/week, increasing by 2.5 mg every 4 weeks up to a 515 mg/week maintenance dose, injected once weekly
US$ 24.98
US$ 21.80
US$ 28.25
US$ 24.58
US$ 28.82
US$ 26.61
US$ 27.46
US$ 20.80
US$ 28.84
US$ 21.01
US$ 24.96
US$ 23.59
US$ 22.95
US$ 21.96
